Acute Variceal Bleeding in Liver Cirrhosis When First-Line Combination Therapy Has Not Achieved Haemostasis
In patients with liver cirrhosis presenting with acute variceal bleeding, certain high-risk presentations require a defined escalation pathway when initial haemostatic management does not achieve durable bleeding control.
Who This Protocol Applies To
Patients with liver cirrhosis and acute variceal bleeding who meet at least one of the following high-risk criteria:
- Child–Pugh class C (score below 14 points)
- Child–Pugh class B (score above 7 points) with active bleeding confirmed at initial endoscopy
- Hepatic venous pressure gradient (HVPG) above 16 mmHg at the time of haemorrhage
First-Line Failure Condition
This protocol is indicated when the combination of a vasoactive drug and endoscopic therapy — the recommended first-line approach in this high-risk setting — has not achieved its defining target: cessation of bleeding with haemodynamic stability sustained for at least 48 hours. When that threshold is not met, escalation to a more definitive intervention is required.
Next-Step Treatment Approach
For high-risk patients with liver cirrhosis in whom first-line therapy has failed, the evidence supports an early transjugular portosystemic shunting procedure (TIPS). The full protocol specifies the exact indication criteria, the critical timing window, and the technical considerations that meaningfully affect outcomes.
References
- Pre-emptive TIPS with PTFE covered stents within 72 h (ideally < 24 h) reduces re-bleeding and improves survival in carefully selected patients who met any of the following criteria: Child–Pugh class C < 14 points or Child–Pugh class B > 7 with active bleeding at initial endoscopy or HVPG > 16 mmHg at the time of hemorrhage.
- Pre-emptive TIPS is recommended as the first-line treatment in high-risk patients with cirrhosis presenting with AVB, as it significantly improves survival outcomes.
- Eight mm TIPS should be preferred over 10 mm TIPS for control of bleeding.